Neuro disorder biotech Protagenic Therapeutics prices upsized Nasdaq uplisting at $4.15 midpoint

renaissancecap...2021-04-28

Protagenic Therapeutics, an early stage biotech developing therapies for stress-related neuropsychiatric and mood disorders, raised $13 million by offering 3.2 million units at $4.15, the midpoint of ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

the_bald_statement
2021-04-28
the_bald_statement
Like pls
- Timtan85:
  Like n comment
- the_bald_statement:
  Sure
- cozyli:
  done..pls reply.thanks

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1179831996?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-04-28 10:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179831996","market":"us","top_or_hot":-1,"title":"Neuro disorder biotech Protagenic Therapeutics prices upsized Nasdaq uplisting at $4.15 midpoint","media":"renaissancecap...","content":"<div>\n<p>Protagenic Therapeutics, an early stage biotech developing therapies for stress-related neuropsychiatric and mood disorders, raised $13 million by offering 3.2 million units at $4.15, the midpoint of ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/81179/Neuro-disorder-biotech-Protagenic-Therapeutics-prices-upsized-Nasdaq-uplist\">Source Link</a>\n\n</div>\n","source":"lsy1619493174116","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Neuro disorder biotech Protagenic Therapeutics prices upsized Nasdaq uplisting at $4.15 midpoint</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNeuro disorder biotech Protagenic Therapeutics prices upsized Nasdaq uplisting at $4.15 midpoint\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-28 10:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/81179/Neuro-disorder-biotech-Protagenic-Therapeutics-prices-upsized-Nasdaq-uplist><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Protagenic Therapeutics, an early stage biotech developing therapies for stress-related neuropsychiatric and mood disorders, raised $13 million by offering 3.2 million units at $4.15, the midpoint of ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/81179/Neuro-disorder-biotech-Protagenic-Therapeutics-prices-upsized-Nasdaq-uplist\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PTIX","symbol_name":"Protagenic Therapeutics Inc","start_time":0,"source_url":"https://www.renaissancecapital.com/IPO-Center/News/81179/Neuro-disorder-biotech-Protagenic-Therapeutics-prices-upsized-Nasdaq-uplist","article_id":"1179831996","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179831996","pubTimestamp":1619577019,"columns":[],"sourceInfo":{"source_id":"lsy1619493174116","name":"renaissancecapital"},"weMediaInfo":null,"summary":"Protagenic Therapeutics, an early stage biotech developing therapies for stress-related neuropsychia","collect":0,"end_time":0,"defaultTopTitle":"renaissancecapital.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PTIX":"Protagenic Therapeutics Inc"},"translate_title":"神经紊乱生物技术主角疗法价格上涨纳斯达克上升到4.15美元中点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PTIX":0.9},"content_text":"Protagenic Therapeutics, an early stage biotech developing therapies for stress-related neuropsychiatric and mood disorders, raised $13 million by offering 3.2 million units at $4.15, the midpoint of the range of $4.13 to $4.17. The company sold 0.5 million more units than anticipated. Each unit consists of one share of common stock and one warrant, exercisable at $4.98. At pricing, the company commands a fully diluted market value of $85 million.Because the company offered units with warrants attached, Protagenic Therapeutics will be excluded from Renaissance Capital's stats.\nThe company specializes in the discovery and development of therapeutics for stress-related neuropsychiatric and mood disorders, utilizing synthetic forms of endogenous brain signaling peptides that can dampen overactive stress responses. Its lead compound, PT00114, is a 41-residue peptide synthetic form of TCAP that can be administered subcutaneously, sublingually, or intra-nasally. The company intends to complete IND-enabling studies of PT00114 and enter first-in-human Phase 1/2 studies in the 3Q21.\nProtagenic Therapeutics plans to list on the Nasdaq under the symbol PTIX. Kingswood Capital Markets acted as a lead manager on the deal.","kind":"news","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":100977351,"gmtCreate":1619577621573,"gmtModify":1704726237522,"author":{"id":"3571799401375817","authorId":"3571799401375817","name":"the_bald_statement","avatar":"https://community-static.tradeup.com/news/86fee15cce96279172dbb4329cbe127e","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":7,"crmLevelSwitch":1,"idStr":"3571799401375817","authorIdStr":"3571799401375817"},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/100977351","repostId":1179831996,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4156721,"gmtCreate":1619577967758,"gmtModify":1680785963498,"authorId":3573460795152662,"author":{"id":3573460795152662,"idStr":"3573460795152662","authorId":3573460795152662,"name":"Timtan85","avatar":"https://static.tigerbbs.com/5ac241a703d94ceba483abb0655d0b6b","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.09","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":100977351,"type":1,"supId":0,"prevId":0,"content":"Like n comment","text":"Like n comment","html":"Like n comment"},{"id":4156656,"gmtCreate":1619577708441,"gmtModify":1680785949753,"authorId":3571799401375817,"author":{"id":3571799401375817,"idStr":"3571799401375817","authorId":3571799401375817,"name":"the_bald_statement","avatar":"https://community-static.tradeup.com/news/86fee15cce96279172dbb4329cbe127e","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.29","exceedPercentage":"93.06%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":7,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":100977351,"type":1,"supId":4156653,"prevId":0,"content":"Sure","text":"Sure","html":"Sure"},{"id":4156653,"gmtCreate":1619577689427,"gmtModify":1680785948822,"authorId":3574167470846346,"author":{"id":3574167470846346,"idStr":"3574167470846346","authorId":3574167470846346,"name":"cozyli","avatar":"https://static.tigerbbs.com/509ef7c09d0624801748249c5a3e0117","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":100977351,"type":1,"supId":0,"prevId":0,"content":"done..pls reply.thanks","text":"done..pls reply.thanks","html":"done..pls reply.thanks"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":5,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1179831996"}